T cell immunoreceptor with Ig and ITIM domains

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

TIGIT or T Cell Immunoreceptor With Ig And ITIM Domains, alternatively known as WUCAM or Vstm3 or VSIG9 is a protein and antibody which has an important role in the immune system.[1][2] The gene that encodes the TIGIT antibody may also be referred to as TIGIT.[3]

Function[edit | edit source]

TIGIT is an emerging immune checkpoint, and a number of drugs targeting TIGIT are undergoing clinical trials for a number of types of cancer.[2][3]

ME/CFS[edit | edit source]

Fibromyalgia[edit | edit source]

A 2021 study by Verma et al. using immune profiling that TIGIT may have an important role in fibromyalgia.[1]

Notable studies[edit | edit source]

  • 2021, Unbiased immune profiling reveals a natural killer cell-peripheral nerve axis in fibromyalgia[1] - (Abstract)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 Verma, Vivek; Drury, Gillian L.; Parisien, Marc; Özdağ Acarli, Ayşe N.; Al-Aubodah, Tho-Alfakar; Nijnik, Anastasia; Wen, Xia; Tugarinov, Nicol; Verner, Maria; Klares, Richie III; Linton, Alexander (March 4, 2022). "Unbiased immune profiling reveals a natural killer cell-peripheral nerve axis in fibromyalgia". PAIN. doi:10.1097/j.pain.0000000000002498. ISSN 0304-3959. PMC 8942876. PMID 34913882.CS1 maint: PMC embargo expired (link)
  2. 2.0 2.1 Harjunpää, H.; Guillerey, C. (May 2020). "TIGIT as an emerging immune checkpoint". Clinical and Experimental Immunology. 200 (2): 108–119. ISSN 1365-2249. PMID 31828774.
  3. 3.0 3.1 "T cell immunoreceptor with Ig and ITIM domains - Gene card". Gene cards. Retrieved May 1, 2022.